Cell Culture Company
For over 30 years, the Cell Culture Company has been delivering biologics production solutions for preclinical to commercial stages, in mg to kg quantities. The organization serves the diagnostic, therapeutic and animal health industries. It is also home to the National Cell Culture Center, an NIH-founded initiative that provides subsidized services to academic research institutions.
Cell Culture Company is headquartered in Minneapolis, Minnesota. Its 33,000 square foot facility hosts corporate offices, hollow fiber bioreactor manufacturing and distribution operations, and GMP mammalian whole cell and protein production labs.
Job Title: Director of BD
Job Title: Vice President of Bioservices,
New Technologies to Facilitate 3D Bioprinting of Transplantable Organs
Advances in 3D bio-printing have led to an explosion in publications to address the challenges in building living tissue constructs in the shape of human organs. Highlighted below are four innovative technologies developed this year by researchers to tackle some of the biggest problems in the quest to print 3D organs....Continued
De-risking early stage clinical trials – an upstream continuous production solution for biologics
In this mini-webinar, Scott Waniger, VP Bioprocessing, Cell Culture Company, presents a cost effective, early stage clinical trial production process. This process utilizes a continuous upstream manufacturing approach, which reduces production time, lowers cost and ... Continued
The Top 10 Cell Culture Dish Cool Tools Features in 2015
I have compiled a list of our most popular Cool Tools Features for 2015. Here are the top ten in alphabetical order....Continued
mAbVault for Antibody Manufacturing: Protect Quality, Minimize Expenses, and Simplify Scale-up
mAbVault is a network of Contract Research Organizations (CROs) and Contract Manufacturing Organizations (CMOs) with expertise in hollow fiber bioreactors (HFBR). HFBR is a technology platform that has quietly become known for consistency in yields and quality, minimized start-up costs and seamless scale-up....Continued